Annie is a specialist corporate lawyer with expertise in domestic and cross-border mergers, acquisitions and divestments, equity capital markets transactions, private securities offerings, joint ventures and other high value transactions. She also regularly advises on NZX and securities law compliance and foreign investment into New Zealand.
Annie acts for clients in a variety of industries including healthcare, agriculture and dairy, corporate real estate and telecommunications. She is the legal adviser to a number of NZX and/or ASX listed entities, including The a2 Milk Company, Argosy Property, Green Cross Health and National Storage REIT.
Before joining Harmos Horton Lusk, Annie was a corporate associate at Bell Gully.
A number of the transactions on which Annie has advised have been nominated for industry awards. Annie was also a finalist in the Young Private Practice Lawyer of the Year (35 and Younger) category at the 2018 NZ Law Awards.
Advised major shareholder of Dairy Holdings Limited on design and implementation of sales process leading to introduction of Canada's Public Sector Pension Investment Board as a strategic 24.9% shareholder
Advised ASX listed Centuria Capital Group on its successful $172 million cash and scrip takeover offer for Augusta Capital, including on its urgent application for Overseas Investment Office consent
Advised the independent directors of NZX listed Investore Property Limited on two underwritten placements and share purchase plans with aggregate value of $180 million
Advised FCL Metering (a wholly owned subsidiary of The Lines Company Limited) on the acquisition of Trustpower Limited's electricity meter assets and meter equipment provider business
Advised the board of NZX Main Board/ASX listed The a2Milk Company Limited on its NZ$162 million acquisition of Synlait Milk shares from Mitsui & Co
Advised NZX Main Board listed Pushpay Holdings Limited on the block trade of one of its co-founders’ stake in the company for NZ$100 million
Advised ASX listed National Storage REIT on various bolt-on business and real property acquisitions in New Zealand
Advised AFT Pharmaceuticals on the initial offering of its shares on the NZX Main Board and ASX, with an initial market capitalisation of NZ$310 million